Antibiotic medicine franchise in Ahmedabad

Infection care tablet supplier in Mumbai

Anti-infective medicine distributor in Delhi

Ciprofloxacin Ornidazole tablet manufacturer in Bangalore

Antibiotic medicine stockist in Hyderabad
Anti-infective medicine exporter in Chandigarh

Home/Products /ciprofloxacin-500mg-ornidazole-500mg-tablet

About the Product

Description


Ciproplit O Tablet containing Ciprofloxacin and Ornidazole is used for the management of mixed bacterial and protozoal infections. It helps control infection-causing organisms and supports faster recovery.

Ciprofloxacin works as a fluoroquinolone antibiotic that inhibits bacterial DNA replication, while Ornidazole acts against protozoal and anaerobic infections, providing broad-spectrum anti-infective coverage.

The tablet is widely prescribed for gastrointestinal infections, dental infections, gynecological infections, and other mixed infection conditions, leading to consistent prescription demand.

With increasing prevalence of mixed infections and growing demand for effective combination therapies, this product offers strong business potential for retailers and distributors. Its dual-action formulation, broad clinical relevance, and steady market demand make it a reliable product for growth in the anti-infective segment.

Some patients may experience nausea, vomiting, abdominal pain, diarrhea, headache, dizziness, metallic taste, or loss of appetite. Rarely, allergic reactions, tendon inflammation, nervous system effects (such as confusion or seizures), or liver function abnormalities may occur and require immediate medical attention.

Ciproplit O Tablet is indicated for acute diarrhea, dysentery, gastrointestinal infections, mixed bacterial-protozoal infections, typhoid fever, and other abdominal infections caused by susceptible organisms. It helps reduce infection severity, control symptoms, and promote faster recovery.

This medicine should be used strictly under medical supervision. Avoid alcohol during treatment and for at least 48 hours after completion due to Ornidazole. Complete the full prescribed course even if symptoms improve early to prevent resistance and recurrence. Use cautiously in patients with liver disease, kidney impairment, or a history of tendon disorders.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Ciprofloxacin 500mg + Ornidazole 500mg Tablet in the PCD pharma franchise market?

Ciprofloxacin 500mg + Ornidazole 500mg Tablet has strong demand in the anti-infective, gastrointestinal, and general medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on broad-spectrum infection management portfolios.

Why should medical distributors include Ciprofloxacin + Ornidazole Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for mixed bacterial and protozoal infection management under medical supervision. Ciprofloxacin 500mg is a broad-spectrum antibiotic effective against various bacterial infections Ornidazole 500mg is an antiprotozoal and anaerobic antibacterial agent Commonly prescribed for diarrhea, dysentery, gastrointestinal infections, abdominal infections, and mixed bacterial-protozoal infections Helps provide comprehensive coverage for GI and anaerobic infections Widely used by general physicians and gastroenterologists This strengthens a strong anti-infective and gastrointestinal portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ciprofloxacin 500mg + Ornidazole 500mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong demand in general medicine practice, gastrointestinal infection treatments, repeat prescriptions, reliable supply chain support, and attractive margins in the anti-infective segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.